IT @ Networking Awards 2012 - Raise Awareness of the World's Most Innovative Healthcare IT Projects

18 - 19 January 2012, Brussels, Belgium.
The IT @ Networking Awards 2012 (IT @ 2012) is an open competition for implemented, fully operable healthcare IT and medical technology solutions in healthcare. The goal is to raise awareness of some of the world's finest and most innovative local, regional and national healthcare IT projects.

Recognition
High-tech, high-cost medicine; ageing populations; patient mobility and staff shortages are only some of the challenges healthcare providers face today. Intelligent IT solutions increase cost-effectiveness, productivity and safety and help healthcare facilities to confront these problems. IT @ 2012 brings these innovations into the global spotlight and provides them with the recognition and media attention they deserve.

Their stories will inspire others, proving that challenges can be transformed into future opportunities and success stories.

Novel and Interactive
The core aim of IT @ 2012 is to learn from the mistakes and achievements of different top IT installations. The unique peer-to-peer voting system empowers daily users such as CEOs, CIOs, CMIOs, hospital and IT managers to vote for their preferred projects, as they are best placed to judge the real value of projects.

First Day - MindByte Session
All Nominees will present in the MindByte, a five minute introductory presentation followed by a lively five minute Q&A. The qualifying audience will vote immediately after each presentation according to the voting criteria for their favourite solution.

Becoming a Nominee is a huge achievement and each will be awarded the prestigious IT @ 2012 Nominee Silver Medal.

Second Day - WorkBench Session
The nine top-rated Nominees will progress as Finalists into the next day WorkBench, a 30-minute in-depth presentation followed by a 15 minute Q&A discussion, providing the audience with a thorough understanding of the project. The qualifying audience will vote immediately after each presentation to choose the winners. Finalists will be awarded the prestigious IT @ 2012 Finalist Gold Medal.

The Prize
The top three IT solutions will be awarded a prize.

The winning Project will receive:

  • The IT @ Networking Awards 2012 Trophy;
  • A cash prize of € 5,000;
  • Media promotion in Europe's leading healthcare management media worth € 50,000.

The 2nd Project will receive:

  • The IT @ Networking Awards 2012 Trophy;
  • Media promotion in europe’s leading healthcare management media worth € 25,000.

The 3rd Project will receive:

  • The IT @ Networking Awards 2012 Trophy.

For further information, please visit:
http://www.itandnetworking.org

Most Popular Now

Aspirin green light for brain bleed stroke patient…

People who suffer a stroke caused by bleeding in the brain - known as brain haemorrhage - can take common medicines without raising their risk of another stroke, a major ...

Cancer cells are quick-change artists adapting to …

Until now, researchers have assumed that the growth of solid tumors originates from cancer stem cells characterized by specific surface markers, which develop in a fixed...

APRINOIA Therapeutics awarded grant from The Micha…

APRINOIA Therapeutics, a clinical-stage biotechnology company with a pipeline of therapeutics and imaging diagnostics for neurodegenerative diseases, announces today that...

Benralizumab not effective reducing exacerbations …

More than 15.3 million people in the U.S. suffer from chronic obstructive pulmonary disease (COPD), which is the third leading cause of death in this country, according t...

Pfizer announces top-line results from Phase 3 Tri…

Pfizer Inc. (NYSE: PFE) announced today that a Phase 3 study to assess the use of LYRICA® (pregabalin) as adjunctive therapy for epilepsy patients 5 to 65 years of age wi...

Novartis phase II data for new inhaled combination…

Novartis announced today that new phase II data for IND/GLY/MF (QVM149), an investigational, once-daily, fixed dose combination asthma treatment containing indacaterol ac...

New data show Symbicort reduces attacks in mild as…

New data from Novel START, an open-label trial designed to reflect real-world practice, has demonstrated the effectiveness of Symbicort Turbuhaler (budesonide/formoterol)...

Cannabis use among older adults rising rapidly

Cannabis use among older adults is growing faster than any other age group but many report barriers to getting medical marijuana, a lack of communication with their docto...

Merck pioneers new effort to see MS from the insid…

Merck, a leading science and technology company, joins the global multiple sclerosis (MS) community in recognition of World MS Day, an initiative created by the Multiple ...

Amgen joins with community oncology networks for n…

Amgen (NASDAQ: AMGN), along with leading community oncology networks, today announced the launch of Amgen Community Oncology Research Collaborators (ACORC), a new initiat...

Bayer receives U.S. FDA breakthrough therapy desig…

Bayer announced today that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation for copanlisib (Aliqopa™) for the treatment of adult patie...

Roche's personalised medicine entrectinib shrank t…

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced positive data from the Phase I/II STARTRK-NG study, evaluating the investigational medicine entrectinib in children and adole...